The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Inhibition of Stat3 Activation Suppresses Caspase-3 and the Ubiquitin-Proteasome System, Leading to Preservation of Muscle Mass in Cancer Cachexia
Open accessAbstract
Cachexia occurs in patients with advanced cancers. Despite the adverse clinical impact of cancer-induced muscle wasting, pathways causing cachexia are controversial, and clinically reliable therapies are not available. A trigger of muscle protein loss is the Jak/Stat pathway, and indeed, we found that conditioned medium from C26 colon carcinoma (C26) or Lewis lung carcinoma cells activates Stat3 (p-Stat3) in C2C12 myotubes. We identified two proteolytic pathways that are activated in muscle by p-Stat3; one is activation of caspase-3, and the other is p-Stat3 to myostatin, MAFbx/Atrogin-1, and MuRF-1 via CAAT/enhancer-binding protein δ (C/EBPδ). Using sequential deletions of the caspase-3 promoter and CHIP assays, we determined that Stat3 activation increases caspase-3 expression in C2C12 cells. Caspase-3 expression and proteolytic activity were stimulated by p-Stat3 in muscles of tumor-bearing mice. In mice with cachexia caused by Lewis lung carcinoma or C26 tumors, knock-out of p-Stat3 in muscle or with a small chemical inhibitor of p-Stat3 suppressed muscle mass losses, improved protein synthesis and degradation in muscle, and increased body weight and grip strength. Activation of p-Stat3 stimulates a pathway from C/EBPδ to myostatin and expression of MAFbx/Atrogin-1 and increases the ubiquitin-proteasome system. Indeed, C/EBPδ KO decreases the expression of MAFbx/Atrogin-1 and myostatin, while increasing muscle mass and grip strength. In conclusion, cancer stimulates p-Stat3 in muscle, activating protein loss by stimulating caspase-3, myostatin, and the ubiquitin-proteasome system. These results could lead to novel strategies for preventing cancer-induced muscle wasting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our data are in accordance with previous reports showing that gp130 via the JAK/STAT pathway mediates muscle atrophy in a cancer cachexia mouse model. 15 , 27 , 28”
From Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting (2022) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition of STAT3 with TTI-101 reversed muscle loss in both cachexia models by suppressing the expression of MAFbx/Atrogin-1 and MuRF1 and reducing caspase-3 activity”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Silva et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The link between IL-6/STAT3 signaling and muscle and adipose tissue wasting is well established in mouse models of cachexia (White et al., 2011; Silva et al., 2015) and has been reinforced preliminarily in clinical studies.”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Silva et al., 2015
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Levels of pY-STAT3 are increased in skeletal muscle in mouse models of cachexia, including models of chronic kidney disease (Zhang et al., 2013a) and cancer (Silva et al., 2015).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Silva et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Evans, W., Morley, J., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,341
Self-citationTisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,216
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,163
Self-citationTisdale, M. J. (2002) · Nature reviews. Cancer · doi:10.1038/nrc927 · Cited by 993
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T. C., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 960
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigaré, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 730
Self-citationPathophysiologic Response to Severe Burn Injury
Jeschke, M. G., Chinkes, D. L., Finnerty, C. C., Kulp, G. A., Suman-Vejas, O. E., Norbury, W. B., Branski, L. K., Gauglitz, G. G., Mlcak, R. P., & Herndon, D. N. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181856241 · Cited by 719
Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Self-citation
Cited by
Sorted by citations
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis
Eskandari, E., & Eaves, C. J. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202201159 · Cited by 504
Skeletal muscle atrophy: From mechanisms to treatments
Yin, L., Li, N., Jia, W., Wang, N., Liang, M., Yang, X., & Du, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105807 · Cited by 423
Inflammation and Skeletal Muscle Wasting During Cachexia
Webster, J. M., Kempen, L. J. A. P., Hardy, R. S., & Langen, R. C. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.597675 · Cited by 372
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y. T., Julianto, N. M., Muhammad, J. A., Lee, H., Chae, J. H., & Kwon, H. Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 342
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
Self-citationInflammation: Roles in Skeletal Muscle Atrophy
Ji, Y., Li, M., Chang, M., Liu, R., Qiu, J., Wang, K., Deng, C., Shen, Y., Zhu, J., Wang, W., et al. (2022) · Antioxidants · doi:10.3390/antiox11091686 · Cited by 329
Hughes, L., Rosenblatt, B., Haddad, F. S., Gissane, C., McCarthy, D., Clarke, T. R., Ferris, G., Dawes, J., Paton, B. M., & Patterson, S. D. (2019) · Sports Medicine · doi:10.1007/s40279-019-01137-2 · Cited by 276
Skeletal Muscle Wasting and Renewal: A Pivotal Role of Myokine IL-6
Belizário, J. E., Fontes-Oliveira, C. C., Borges, J. P., Kashiabara, J. A., & Vannier, E. (2016) · SpringerPlus · doi:10.1186/s40064-016-2197-2 · Cited by 244
Perry, B. D., Caldow, M. K., Brennan‐Speranza, T. C., Sbaraglia, M., Jerums, G., GARNHAM, A. P., Wong, C. Y., Levinger, P., Haq, M. A. U., Hare, D. L., et al. (2016) · PubMed · Cited by 239
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
Zanders, L., Kny, M., Hahn, A., Schmidt, S., Wundersitz, S., Todiras, M., Lahmann, I., Bandyopadhyay, A., Wollersheim, T., Kaderali, L., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12867 · Cited by 225
“ates muscle atrophy in a cancer cachexia mouse model.(15,27,28) Specifically, increased IL-6 plasma levels are associated with cachexia in various models of cancer, such as”
BackgroundSTAT3 in the systemic inflammation of cancer cachexia
Zimmers, T. A., Fishel, M. L., & Bonetto, A. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.02.009 · Cited by 231
Signaling Pathways That Control Muscle Mass
Vainshtein, A., & Sandri, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134759 · Cited by 222
Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
Self-citationBarreto, R., Waning, D. L., Gao, H., Liu, Y., Zimmers, T. A., & Bonetto, A. (2016) · Oncotarget · doi:10.18632/oncotarget.9779 · Cited by 205
Chen, M., Wang, Y., Deng, S., Lian, Z., & Yu, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.964130 · Cited by 187
Cytokine Signaling in Skeletal Muscle Wasting
Zhou, J., Liu, B., Liang, C., Li, Y., & Song, Y.-H. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.03.002 · Cited by 172
miRNA‐23a/27a attenuates muscle atrophy and renal fibrosis through muscle‐kidney crosstalk
Zhang, A., Li, M., Wang, B., Klein, J. D., Price, S. R., & Wang, X. H. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12296 · Cited by 152
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
Rausch, V., Sala, V., Penna, F., Porporato, P. E., & Ghigo, A. (2021) · Oncogenesis · doi:10.1038/s41389-020-00288-6 · Cited by 149
The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
Moresi, V., Adamo, S., & Berghella, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00500 · Cited by 145
MuRF1/TRIM63, Master Regulator of Muscle Mass
Peris-Moreno, D., Taillandier, D., & Polge, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186663 · Cited by 144
STAT3 promotes IFNγ/TNFα‐induced muscle wasting in an NF‐κB‐dependent and IL‐6‐independent manner
Ma, J. F., Sánchez, B. J., Hall, D. T., Tremblay, A. K., Marco, S. D., & Gallouzi, I. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607052 · Cited by 143
Protein breakdown in cancer cachexia
Sandri, M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.002 · Cited by 134
Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism
Lombardi, G., Ziemann, E., Banfi, G., & Corbetta, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155388 · Cited by 131
A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
Seto, D. N., Kandarian, S. C., & Jackman, R. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638411 · Cited by 123
The beneficial role of proteolysis in skeletal muscle growth and stress adaptation
Bell, R. A. V., Al-Khalaf, M. H., & Megeney, L. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0086-6 · Cited by 124
Cancer Cachexia and Related Metabolic Dysfunction
da Fonseca, G. W. P., Farkaš, J., Dora, E., von Haehling, S., & Lainščak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072321 · Cited by 122
Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
Huang, Z., Zhong, L., Zhu, J., Xu, H. Z., Ma, W., Zhang, L., Shen, Y., Law, B. Y. K., Ding, F., Gu, X., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-7269 · Cited by 114
Self-citationOut of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
Haberecht-Müller, S., Krüger, E., & Fielitz, J. (2021) · Biomolecules · doi:10.3390/biom11091327 · Cited by 108
Ubiquitin-proteasome pathway in skeletal muscle atrophy
Pang, X., Zhang, P., Chen, X., & Liu, W. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1289537 · Cited by 120
Gavino, A. C., Nahmod, K., Bharadwaj, U., Makedonas, G., & Tweardy, D. J. (2016) · Allergy · doi:10.1111/all.12937 · Cited by 114
Self-citationSTAT3 in Skeletal Muscle Function and Disorders
Guadagnin, E., Mázala, D. A. G., & Chen, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082265 · Cited by 93
Hu, W., Ru, Z., Zhou, Y., Xiao, W., Sun, R., Zhang, S., Gao, Y., Li, X., Zhang, X., & Yang, H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.04.006 · Cited by 91
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease
Verzola, D., Barisione, C., Picciotto, D., Garibotto, G., & Koppe, L. (2018) · Kidney International · doi:10.1016/j.kint.2018.10.010 · Cited by 95
Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., & Taillandier, D. (2021) · Molecules · doi:10.3390/molecules26020407 · Cited by 90
Mondrinos, M. J., Alisafaei, F., Yi, A. Y., Ahmadzadeh, H., Lee, I., Blundell, C., Seo, J., Osborn, M., Jeon, T., Kim, S. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe9446 · Cited by 86
Zhang, S., Wang, X., Li, W.-S., Xu, X., Hu, J., Kang, X.-Q., Qi, J., Ying, X., You, J., & Du, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.06.038 · Cited by 84
Dantas, W. S., Zunica, E. R. M., Heintz, E. C., Vandanmagsar, B., Floyd, Z. E., Yu, Y., Fujioka, H., Hoppel, C. L., Belmont, K. P., Axelrod, C. L., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12982 · Cited by 84
Proteasome expression and activity in cancer and cancer stem cells
Voutsadakis, I. A. (2017) · Tumor Biology · doi:10.1177/1010428317692248 · Cited by 81
Sarcopenia is a prognostic outcome marker in children with high‐risk hepatoblastoma
Ritz, A., Kolorz, J., Hubertus, J., Ley‐Zaporozhan, J., von Schweinitz, D., Koletzko, S., Häberle, B., Schmid, I., Kappler, R., Berger, M., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28862 · Cited by 78
Huang, X., Cai, H., Zhou, H., Li, T., Jin, H., Evans, C. E., Cai, J., & Pi, J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.036 · Cited by 77
Ma, W., Zhang, R., Huang, Z., Zhang, Q., Xie, X., Yang, X., Zhang, Q., Liu, H., Ding, F., Zhu, J., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.101 · Cited by 66
Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review
Xu, X. P., Talifu, Z., Zhang, C.-J., Gao, F., Ke, H., Pan, Y., Gong, H., Du, H., Yu, Y. H., Jing, Y.-L., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1099143 · Cited by 70
Diets for patients with chronic kidney disease, should we reconsider?
Mitch, W. E., & Remuzzi, G. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0283-x · Cited by 65
Self-citationMolecular mechanisms of cancer cachexia‑induced muscle atrophy (Review)
Yang, W., Huang, J., Wu, H., Wang, Y., Du, Z., Ling, Y., Wang, W., Wu, Q., & Gao, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11608 · Cited by 67
Pototschnig, I., Feiler, U., Diwoky, C., Vesely, P. W., Rauchenwald, T., Paar, M., Bakiri, L., Pajed, L., Hofer, P., Kashofer, K., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13109 · Cited by 61
Oyabu, M., Takigawa, K., Mizutani, S., Hatazawa, Y., Fujita, M., Ohira, Y., Sugimoto, T., Suzuki, O., Tsuchiya, K., Suganami, T., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101385rr · Cited by 63
Chenette, D. M., Cadwallader, A. B., Antwine, T., Larkin, L. C., Wang, J., Olwin, B. B., & Schneider, R. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.095 · Cited by 59
Hughes, L., Paton, B. M., Haddad, F. S., Rosenblatt, B., Gissane, C., & Patterson, S. D. (2018) · Physical Therapy in Sport · doi:10.1016/j.ptsp.2018.07.002 · Cited by 60
Wu, C., Tang, L., Ni, X., Xu, T., Fang, Q., Xu, L., Ma, W., Yang, X., & Sun, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00665 · Cited by 62
Mallard, J., Hucteau, E., Hureau, T. J., & Pagano, A. F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719643 · Cited by 62
Molecular Insights into Muscle Homeostasis, Atrophy and Wasting
Scicchitano, B. M., Dobrowolny, G., Sica, G., & Musarò, A. (2018) · Current Genomics · doi:10.2174/1389202919666180101153911 · Cited by 52
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Cancer cachexia: molecular basis and therapeutic advances
Tan, Y., Xue, R., Pan, Y., he, Z., Hu, X., Li, Y., Li, K., Zhang, X., Bian, X.-W., & Wang, B. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02331-7 · Cited by 57
Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40
Zhang, L., Chen, Z., Wang, Y., Tweardy, D. J., & Mitch, W. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2019 · Cited by 47
Self-citationImperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3
Chen, L., Xu, W., Yang, Q., Zhang, H., Wan, L., Xin, B., Zhang, J., & Guo, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104871 · Cited by 49
Fan, M., Sun, W., Gu, X., Lu, S., Shen, Q., Liu, X., & Zhang, X. (2022) · Oncogene · doi:10.1038/s41388-021-02151-3 · Cited by 43
Cortez, N. E., & Mackenzie, G. G. (2021) · Nutrients · doi:10.3390/nu13093202 · Cited by 43
The Nutritional Challenges of Cancer Cachexia
Gaafer, O., & Zimmers, T. (2021) · JPEN - Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2287 · Cited by 39
Hoogaars, W. M. H., & Jaspers, R. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_8 · Cited by 44
The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
Penna, F., Ballarò, R., & Costelli, P. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8041 · Cited by 43
Huot, J. R., Pin, F., Narasimhan, A., Novinger, L. J., Keith, A. S., Zimmers, T. A., Willis, M. S., & Bonetto, A. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12642 · Cited by 41
Wijaya, Y. T., Setiawan, T., Sari, I. N., Park, K., Lee, C. H., Cho, K. W., Lee, Y. K., Lim, J., Yoon, J. K., Lee, S. H., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13084 · Cited by 41
Parathyroid hormone stimulates adipose tissue browning
Thomas, S. S., & Mitch, W. E. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000357 · Cited by 40
Self-citationA Pound of Flesh: What Cachexia Is and What It Is Not
Berardi, E., Madaro, L., Lozanoska‐Ochser, B., Adamo, S., Thorrez, L., Bouché, M., & Coletti, D. (2021) · Diagnostics · doi:10.3390/diagnostics11010116 · Cited by 43
Chen, L., Yang, Q., Zhang, H., Wan, L., Xin, B., Cao, Y., Zhang, J., & Guo, C. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113066 · Cited by 39
Muscle wasting: emerging pathways and potential drug targets
Domaniku, A., Bilgiç, Ş. N., & Kır, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.006 · Cited by 41
Management of sarcopenia in patients with rheumatoid arthritis
Torii, M., Itaya, T., Minamino, H., Katsushima, M., Fujita, Y., Tanaka, H., Oshima, Y., Watanabe, R., Ito, H., Arai, H., et al. (2022) · Modern Rheumatology · doi:10.1093/mr/roac095 · Cited by 39
Regulation of Skeletal Muscle DRP-1 and FIS-1 Protein Expression by IL-6 Signaling
Fix, D. K., VanderVeen, B. N., Counts, B. R., & Carson, J. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8908457 · Cited by 39
Shen, Q., Kuang, J., Miao, C., Zhang, W., Li, Y.-W., Zhang, X., & Liu, X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153858 · Cited by 36
Tu, S., Hao, X., Xu, S., Jin, X., Liao, W., Xia, H., Wang, S., & Sun, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146740 · Cited by 46
The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction
Tang, H., & Shrager, J. B. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0022tr · Cited by 36
Invited review: Muscle protein breakdown and its assessment in periparturient dairy cows
Sadri, H., Ghaffari, M. H., & Sauerwein, H. (2022) · Journal of Dairy Science · doi:10.3168/jds.2022-22068 · Cited by 43
CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding
Wang, L., Feng, J., Deng, Y., Yang, Q., Wei, Q., Ye, D., Rong, X., & Guo, J. (2022) · Research · doi:10.34133/2022/9891689 · Cited by 35
Sala, D., & Sacco, A. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000273 · Cited by 36
Luo, J., Liang, A., Liang, M., Xia, R., Rizvi, Y. Q., Wang, Y., & Cheng, J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080867 · Cited by 34
Muscle–bone interactions: movement in the field of mechano–humoral coupling of muscle and bone
Cardozo, C. P., & Graham, Z. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13411 · Cited by 32
Liva, S. G., Tseng, Y., Dauki, A. M., Sovic, M. G., Vu, T. T., Henderson, S. E., Kuo, Y., Benedict, J., Zhang, X., Remaily, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201809910 · Cited by 33
Niu, M., Song, S., Su, Z., Wei, L., Li, L., Pu, W., Zhao, C., Ding, Y., Wang, J., Cao, W., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15625 · Cited by 35
Hu, Y., Liu, F., Jia, X., Wang, P., Gu, T., Liu, H., Liu, T., Wei, H., Chen, H., Zhao, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01817-2 · Cited by 34
Exosomal Plasminogen Activator Inhibitor-1 Induces Ionizing Radiation-Adaptive Glioblastoma Cachexia
Shin, E., Kang, H., Lee, H., Lee, S., Jeon, J., Seong, K. M., Youn, H., & Youn, B. (2022) · Cells · doi:10.3390/cells11193102 · Cited by 33
Qaed, E., Wang, J., Almoiliqy, M., Song, Y., Liu, W., Chu, P., Alademi, S., Alademi, M., Li, H., Alshwmi, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6521218 · Cited by 34
Oncostatin M signaling drives cancer-associated skeletal muscle wasting
Domaniku, A., Agca, S., Toledo, B., Sucuoglu, M., Özen, S. D., Bilgiç, Ş. N., Arabacı, D. H., Kashgari, A. E., & Kır, S. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101498 · Cited by 31
Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation
Yu, Y., Xu, Y., Lan, X., Liu, X., Zhang, X., Gao, X., & Geng, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.047 · Cited by 32
Huot, J. R., Novinger, L. J., Pin, F., Narasimhan, A., Zimmers, T. A., O’Connell, T. M., & Bonetto, A. (2020) · JCI Insight · doi:10.1172/jci.insight.136687 · Cited by 32
IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway
Ying, L., Yao, Y., Lv, H., Lu, G., Zhang, Q., Yang, Y., & Zhou, J. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00463.2021 · Cited by 29
Au, E., Desai, A., Koniaris, L., & Zimmers, T. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2016.00682 · Cited by 27
Mechanisms Regulating Muscle Protein Synthesis in CKD
Zhang, L., Chen, Q., Chen, Z., Wang, Y., Gamboa, J. L., Ikizler, T. A., Garibotto, G., & Mitch, W. E. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019121277 · Cited by 29
Self-citationAnoveros‐Barrera, A., Bhullar, A. S., Stretch, C., Dunichand‐Hoedl, A. R., Martins, K. J. B., Rieger, A. M., Bigam, D. L., McMullen, T. P. W., Bathe, O. F., Putman, C. T., et al. (2019) · Skeletal Muscle · doi:10.1186/s13395-019-0209-y · Cited by 28
Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice
Kobayashi, M., Kasamatsu, S., Shinozaki, S., Yasuhara, S., & Kaneki, M. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00161.2020 · Cited by 30
Yang, X., Li, M., Ji, Y., Lin, Y., Xu, L., Gu, X., Sun, H., Wang, W., Shen, Y., Liu, H., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.923190 · Cited by 28
Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture
Jackman, R. W., Floro, J., Yoshimine, R., Zitin, B., Eiampikul, M., El-Jack, K., Seto, D. N., & Kandarian, S. C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00738 · Cited by 28
Guo, D., Wang, C., Wang, Q., Qiao, Z., & Tang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.17387 · Cited by 27
RBP4 promotes denervation‐induced muscle atrophy through STRA6‐dependent pathway
Zhang, K., Li, J., Xu, J., Shen, Z., Lin, Y., Zhao, C., Lü, X., Rui, Y., & Gao, W. Q. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13518 · Cited by 25
Singh, A. P., Yadav, A., Phogat, J., & Dabur, R. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210806163851 · Cited by 26
Ma, R., Ma, C., Hu, K., Zhao, M., Zhang, N., & Sun, Z. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5395 · Cited by 26
Oxaliplatin induces muscle loss and muscle‐specific molecular changes in Mice
Feather, C. E., Lees, J. G., Makker, P. G. S., Goldstein, D., Kwok, J. B., Moalem‐Taylor, G., & Polly, P. (2017) · Muscle & Nerve · doi:10.1002/mus.25966 · Cited by 26
Préau, S., Ambler, M. T., Sigurtà, A., Kleyman, A., Dyson, A., Hill, N. E., Boulanger, É., & Singer, M. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00221.2018 · Cited by 25
Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation
Miki, Y., Morioka, T., Shioi, A., Fujimoto, K., Sakura, T., Uedono, H., Kakutani, Y., Ochi, A., Mori, K., Shoji, T., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.143 · Cited by 25
A shared mechanism of muscle wasting in cancer and Huntington's disease
Mielcarek, M., & Isalan, M. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0076-z · Cited by 26
Metadata
- Authors
- Silva, K. A. S., Dong, J., Dong, Y., Dong, Y., Schor, N., Tweardy, D. J., Zhang, L., & Mitch, W. E.
- Affiliations
- Universidade Federal de São Paulo (BR)
- Sichuan University (CN)
- Capital Medical University (CN)
- Baylor College of Medicine (US)
- Corresponding author
- Zhang, Liping
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 290
- Issue
- 17
- Pages
- 11177-11187
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC4409274
- OpenAlex
- W2011567765
- Cited by
- 229
- References
- 52
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 20 · 2023: 23 · 2022: 35 · 2021: 25 · 2020: 27 · 2019: 17 · 2018: 17 · 2017: 16 · 2016: 16 · 2015: 4
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Funders
- National Institutes of Health (R37 DK37175, P50 CA058183, P50 CA097007, R21 CA149783)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- cancer cachexia, STAT3 activation, caspase-3, ubiquitin-proteasome system, C/EBPδ, myostatin, atrogin-1/MAFbx, MuRF1, muscle protein degradation, muscle mass preservation, JAK/STAT signaling, Lewis lung carcinoma, C26 colon carcinoma, muscle protein synthesis
- MeSH terms
- Tripartite Motif Proteins, Animals, Cachexia, Colonic Neoplasms, Muscle Proteins, Mice, Knockout, Muscle, Skeletal, Carcinoma, Lewis Lung, Ubiquitin, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Cell Line, Tumor, Proteasome Endopeptidase Complex, STAT3 Transcription Factor, Mice, CCAAT-Enhancer-Binding Protein-delta, Caspase 3, Myostatin, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
